Adverse reaction reporting United States

Other components in the Echinacea products may contribute to many of the adverse reactions reported, not only Australian, but also the United States, United Kingdom, Canada and New Zealand. Additional studies are needed to further support the IgE-mediated hypersensitivity reported in Echinacea-containing products. Studies could include growing and processing of Echinacea under environmentally controlled conditions, with the intent to minimize foreign contaminants, and administration of extracts to patients under supervision. Although this would not represent real-world conditions, it may further support or refute the IgE-mediated hypersensitivity observed in subjects taking commercial Echinacea products. Additional work is also needed to identify the component responsible for the IgE-mediated hypersensitivity. 

In the United States, adverse reaction reporting for veterinary pharmaceuticals is conducted under a programme operated by the Center for Veterinary Medicine (CVM), which is part of the US Food and Drug Administration (FDA). The FDA provides cumulative veterinary adverse drug experience reports (currently 1987 to 30 April 2012) on its website (http //www.fda.gov/ AnimalVeterinary/default.htm). These reports cover adverse drug reaction... 

Bhananker SM, O Donnell JT, Salem JR, Bishop 25 MJ The risk of anaphylactic reactions to rocuro-nium in the United States is comparable to that of vecuronium an analysis of food and drug administration reporting of adverse events. Anesth Analg 26 2005 101 819. 

Chyka, P.A. and McEommon, S.W. (2000). Reporting of adverse drug reactions by poison control centers in the United States. Drug Safety 23 87-93. 

The United States is one of the only countries that has established a formal surveillance system for post-approval monitoring of adverse reactions to food additives. Despite the obvious limitations of a passive surveillance system, ARMS provides an important venue for the public and others to report health problems perceived to be related to food additives. It provides a means of spotting potential longer-term problems with additives which can then be investigated further. 

As it only recently became widely known in the United States, Salvia divinorum has had limited use. There have been no reports of hospital or emergency room treatment of users for adverse reactions. Negative personal or social consequences of its use have so far gone undetected. Nevertheless, if use of Salvia becomes more widespread, these facts may change. 

It has been reported that there is a ninefold increased risk of having an adverse drug reaction when four or more drugs are taken simultaneously. In addition, 3-5 percent of all hospital admissions are related to adverse drug reactions, and of all the admissions for the elderly, 15-25 percent are complicated by an adverse drug reaction. Some of these reactions are life-threatening, and it is estimated that fatal adverse drug reactions in the United States may run in the thousands each year. 

The results of the extensive intake evaluations in the United States and in other countries demonstrated that intakes which were well below the acceptable daily intakes (ADIs) set by the Food and Drug Administration (FDA) and regulatory bodies in other countries, as well as the Joint FAO/WHO Expert Committee on Food Additives (JFECFA). The studies have also included evaluations of possible associations between aspartame and headaches, seizures, behavior, cognition, and mood as well as allergic-type reactions and use by potentially sensitive subpopulations, has continued after approval. Evaluation of the anecdotal reports of adverse health effects were the first ones done for a food additive, and revealed that the reported effects were generally mild and also common in the general population. 

---